Krystal Biotech, Inc. (KRYS) Financials

KRYS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 818.4 million 39.7 million
2023-09-30 790.4 million 34.4 million
2023-06-30 684.0 million 30.9 million
2023-03-31 531.8 million 42.3 million

KRYS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -9.1 million 9.9 million
2023-09-30 -23.0 million 8.3 million
2023-06-30 -37.0 million 11.3 million
2023-03-31 -31.5 million 10.4 million

KRYS Net Income

No data available :(

KRYS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 532.2 million - 8.1 million
2023-09-30 562.1 million - 8.3 million
2023-06-30 477.5 million - 8.5 million
2023-03-31 350.4 million - 8.8 million

KRYS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 28.8 million
2023-09-30 28.9 million
2023-06-30 26.7 million
2023-03-31 25.7 million

KRYS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1.8 million 11.4 million 24.8 million -
2023-09-30 1.8 million 10.6 million 23.7 million -
2023-06-30 2.8 million 12.1 million 25.9 million -
2023-03-31 5.4 million 12.3 million 24.0 million -

KRYS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 42.1 million 4.4 million
2023-09-30 8.6 million 223000
2023-06-30 - 1.2 million
2023-03-31 - 1.1 million

KRYS

Price: $159.67

52 week price:
82.09
189.97

Earnings Per Share: 0.38 USD

P/E Ratio: -94.90

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 151900

Ebitda: -2.1 million

Market Capitalization: 4.8 billion

Links: